Skip to main content Accessibility help
×
Home

Addressing perceived economic obstacles to genetic testing as a way to mitigate disparities in family health history for adoptees

  • Thomas May (a1) (a2) (a3) and James P. Evans (a4)

Abstract

In this paper, we ask whether or not we can afford to realize the potential benefits of genetic testing as a screening tool for adoptees. Our method is to provide reasonable cost and savings estimates. We argue that the prospect of cost neutrality should be sufficient to explore the targeted screening for a population who will otherwise suffer an avoidable health disparity in access to inherited disease information. Our goal here is to establish that the investment needed to attain these benefits is not beyond our means.

Copyright

Corresponding author

*Correspondence to: Thomas May, Washington State University Vancouver, 14204 Salmon Creek Ave, Vancouver, WA 98686, USA. Email: thomas.may@wsu.edu

References

Hide All
Agalliu, I and Wang, Z (2013) Characteriztion of SNPs associated with prostate cancer in men of Ashkenazic descent from the set of GWAS identified SNPs: impact of cancer family history and cumulative SNP risk prediction. PLoS One, 8, e60083.
American Cancer Society (2016) What are the risk factors for ovarian cancer? http://www.cancer.org/cancer/ovariancancer/detailedguide/ovarian-cancer-risk-factors [9 November 2018].
American Cancer Society (NDa) Genetic Testing, Screening, and Prevention for People with a Strong Family History of Colorectal Cancer. https://www.cancer.org/cancer/colon-rectal-cancer/causes-risks-prevention/genetic-tests-screening-prevention.html [9 November 2018].
American Cancer Society (NDb) Recommendations for Colorectal Cancer Early Detection. https://www.cancer.org/cancer/colon-rectal-cancer/detection-diagnosis-staging/acs-recommendations.html [9 November 2018].
American Cancer Society (NDc) Guidelines for Breast Cancer Screening with MRI as an Adjunct to Mammography. http://onlinelibrary.wiley.com/doi/10.3322/canjclin.57.2.75/full [9 November 2018].
American Gastroenterological Association (ND) Diagnosis and Management of Lynch Syndrome. http://www.gastro.org/guidelines/diagnosis-and-management-of-lynch-syndrome [9 November 2018].
Anglian Breast Cancer Study Group (2000) Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. British Journal of Cancer, 83(10): 13011308.
Bellcross, C (ND) The Genetics of Early-Onset Breast Cancer. https://www.cdc.gov/cancer/breast/pdf/bellcross_gen_br_ca_yng_women.pdf [9 November 2018].
Blumen, H, Fitch, K and Polkus, V (2016) Comparison of treatment costs for breast cancer by tumor stage and type of service. American Health and Drug Benefits, 9(1): 2331.
Cancer.net (ND) Breast Cancer Statistics, http://www.cancer.net/cancer-types/breast-cancer/statistics [9 November 2018].
Chen, S and Parmigiani, G (2007) Meta-analysis of BRCA-1 and BRCA-2 penetrance. J Clin Oncol, 25(11): 13291333.
Classen, L and Henneman, L (2010) Using family history information to promote healthy lifestyles and prevent diseases: a discussion of the evidence. BMC Public Health, 10, 248.
Drugwatch (2015) https://www.drugwatch.com/2015/10/07/cost-of-cancer/ [9 November 2018].
Grosse, S (2015) When is genomic testing cost-effective? Testing for Lynch syndrome in patients with newly-diagnosed colorectal cancer and their relatives. Healthcare (Basel), 3(4):860878. Epub.
Grosse, S, Palomaki, G, Myundura, M and Hampel, H (2015) The cost-effectiveness of routine testing for Lynch syndrome in newly diagnosed patients with colorectal cancer in the United States: corrected estimates. Genetics in Medicine, 17(6): 510511.
Heald, B, Endelman, E and Eng, C (2012) Prospective comparison of family medical history with personal genome screening for risk assessment of common cancers. European Journal of Human Genetics, 20, 547551.
Health Costhelper (NDa) http://health.costhelper.com/mammogram.html [9 November 2018].
Health Costhelper (NDb) http://health.costhelper.com/hysterectomy.html [9 November 2018].
Hynes, D (2012) VA colon cancer quality and costs study: estimating healthcare costs for colon cancer. www.hsrd.research.va.gov/for_researchers/cyber_seminars/archives/hmcs-101712.pdf [9 November 2018].
Johnston, W (2017) Historical statistics on adoption in the U.S., plus statistics on child population and welfare. http://www.johnstonsarchive.net/policy/adoptionstats.html [9 November 2018]. (See also U.S. Census Statistics since 2002).
King, M, Levy-Lahad, E and Lahad, A (2014) Population based screening for BRCA1 and BRCA2: 2014 Lasker award. JAMA, 312(11): 10911092.
Klitzman, R and Chung, W (2010) The process of deciding about prophylactic surgery for breast and ovarian cancer: patient questions, uncertainties, communication. American Journal of Medical Genetics, 152A(1): 5266.
Kuchenbaecker, K, Hopper, J and Barnes, D, et al. (2017) Risk of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA, 317(23): 24022416.
Lerman, C, Hughes, C, Croyle, RT, Main, D, Durham, C, Snyder, C, Bonney, A, Lynch, JF, Narod, SA and Lynch, HT (2000) Prophylactic surgery decisions and surveillance practices one year following BRCA 1/2 testing. Preventive Medicine, 31, 7580.
Louis, L, Christophe, S and Cooper, A (2017) Long-term survival and cost of treatment in patients with Stage IIIC Epithelial Ovarian Cancer. Current Women’s Health Reviews, 13(2): 4450.
May, T, Lee, R and Evans, J (2018) Editors’ introduction: health challenges faced by adopted persons lacking family health history information. Narrative Inquiry in Bioethics, 18(2): 103106.
May, T and Strong, K (2016a) Does lack of genetic relative family health history represent a potentially avoidable health disparity for adoptees? American Journal of Bioethics, 16(12): 3338.
May, T and Evans, J (2016b) Issues of ‘cost, capabilities and scope’ in characterizing adoptees’ lack of genetic relative family health history as an avoidable health disparity. American Journal of Bioethics, 16(12): W4W8.
May, T, Strong, K, Khoury, M and Evans, J (2015) Can targeted genetic testing offer usful health information to adoptees? Genetics in Medicine, 17(7): 533535.
Meijers-Heijboer, EJ, Verhoog, LC, Brekelmans, CTM, Seynaeve, C, Tilanus-Linthorst, MMA, Wagner, A, Dukel, L, Devilee, P, van den Ouweland, AMW, van Geel, AN and Klijn, JGM (2000) Presymptomatic DNA testing and prophylactic surgery in families with a BRCA 1 or BRCA2 mutation. Lancet, 355, 20152020.
Moyer, V, on behalf of the U.S. Preventive Services Task Force (USPSTF) (2014) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women. Annals of Internal Medicine, 160(4): 271282.
Myundra, M, Grosse, S, Hampel, H and Palomaki, G (2010) The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genet Med, 12(2): 93104.
Rosenthal, E (2013) Colonoscopies explain why the U.S. leads the world in health expenditures, New York Times June 1, 2013. http://www.nytimes.com/2013/06/02/health/colonoscopies-explain-why-us-leads-the-world-in-health-expenditures.html?pagewanted=all
Siu, A, on behalf of the U.S. Preventive Services Task Force (2016) Screening for breast cancer: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine, 164(4): 279296.
Smith, M and Hochhalter, A (2011) Utilization of screening mammography among middle-aged and older women. Journal of Women’s Health, 20(11): 16191626.
Quinn, G and Vadaparampil, S (2016) Begging the question: the fallacy of adoptees as a health disparity. American Journal of Bioethics, 16(12): 4748.
Warner, E, Plewes, D and Hill, K (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mommography, and clinical breast examination. JAMA, 292(11): 13171325.
Watson, B (2013) Breast cancer gene: why most women can’t do what Angelina Jolie did. aol.com Finance, https://www.aol.com/2013/05/15/angelina-jolie-breast-cancer-gene-cost/
Yarbroff, K, Borowski, L and Lipsomb, J (2013) Economic studies in colorectal cancer: challenges in measuring and comparing costs. Journal of the National Cancer Institute Monograph, 2013(46): 6278.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed